Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in DSGN — Design Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to DSGN Full portfolio

Position in DSGN

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$967,447
+$696,800 QoQ
Shares Held
66,859
+162.8% QoQ
Ownership
0.107%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 136 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 75% Shared 0% None 25%

Common Shares in DSGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. DSGN ranks #127 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in DSGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $967,447 66,859
2026-03-31 $270,647 25,437
2025-12-31 $236,694 25,234
2025-09-30 $48,018 6,377
2025-06-30 $12,667 3,759
2025-03-31 $15,208 3,940
2024-12-31 $18,874 3,059
2024-09-30 $24,166 4,492
2024-06-30 $27,617 8,244
2024-03-31 $17,373 4,311
2023-12-31 $4,939 1,864
2023-09-30 $1,446 613
2023-06-30 $8,781 1,394
2023-03-31 $5,723 992
2022-12-31 $10,177 992
2022-09-30 $16,586 992
2022-06-30 $32,816 2,344